Phase III Study of Toripalimab Versus Placebo Plus Chemotherapy in Resectable NSCLC

Clinical trial NCT04158440 · COMPLETED

Trial details

NCT number: NCT04158440
Sponsor: Shanghai Junshi Bioscience Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Stage II-III Non-small Cell Lung Cancer

Start date: 2020-04-07
Primary completion: 2026-04-18
Enrollment: 501

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.